iwNHL 2016 | iwNHL 2016 highlights: CAR T-cell therapy, DLBCL and new technologies

Andrew Davies

Andrew Davies, MRCP, PhD of University Hospital of Southampton, Southampton, UK discusses his highlights from the 2016 International Workshop on Non-Hodgkin Lymphoma (iwNHL) meeting held in San Diego, CA. First, Dr Davies explains that the meeting is a great place for discussion. He highlights a session on novel immunotherapies and the discussion around CAR T-cell therapy and how to apply this technology. Further, he mentions bispecific antibodies (BiTEs) and novel monoclonal antibodies. He then highlights the talks on diffuse large B-cell lymphoma (DLBCL) and the application of the cell of origin as well as new technologies and their application in lymphoma, e.g. circulating tumor DNA.

Share this video